These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial. Yu YM, Gao KR, Yu H, Shen YF, Li HF. J Clin Psychopharmacol; 2018 Jun; 38(3):226-233. PubMed ID: 29620692 [Abstract] [Full Text] [Related]
10. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D. Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901 [Abstract] [Full Text] [Related]
11. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS. J Clin Psychiatry; 2008 Apr; 69(4):659-65. PubMed ID: 18363420 [Abstract] [Full Text] [Related]
12. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD. Am J Psychiatry; 2001 Jun; 158(6):906-12. PubMed ID: 11384898 [Abstract] [Full Text] [Related]
13. Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials. Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE. J Clin Psychiatry; 2006 May; 67(5):761-70. PubMed ID: 16841626 [Abstract] [Full Text] [Related]
14. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder. Kroenke K, Messina N, Benattia I, Graepel J, Musgnung J. J Clin Psychiatry; 2006 Jan; 67(1):72-80. PubMed ID: 16426091 [Abstract] [Full Text] [Related]
15. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. Liebowitz MR, Stein MB, Tancer M, Carpenter D, Oakes R, Pitts CD. J Clin Psychiatry; 2002 Jan; 63(1):66-74. PubMed ID: 11838629 [Abstract] [Full Text] [Related]
16. Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. Normann C, Hummel B, Schärer LO, Hörn M, Grunze H, Walden J. J Clin Psychiatry; 2002 Apr; 63(4):337-44. PubMed ID: 12000208 [Abstract] [Full Text] [Related]
17. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K, Sertraline Elderly Depression Study Group. Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242 [Abstract] [Full Text] [Related]
18. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Pezzella G, Moslinger-Gehmayr R, Contu A. Breast Cancer Res Treat; 2001 Nov; 70(1):1-10. PubMed ID: 11766999 [Abstract] [Full Text] [Related]